FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE and COUGH

4,772 reports of this reaction

2.9% of all FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE reports

#4 most reported adverse reaction

Overview

COUGH is the #4 most commonly reported adverse reaction for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, manufactured by GlaxoSmithKline LLC. There are 4,772 FDA adverse event reports linking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE to COUGH. This represents approximately 2.9% of all 162,228 adverse event reports for this drug.

Patients taking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH4,772 of 162,228 reports

COUGH is a less commonly reported adverse event for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, but still significant enough to appear in the safety profile.

Other Side Effects of FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

In addition to cough, the following adverse reactions have been reported for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE:

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

0XYGENACETAMINOPHEN 325 MGACETAMINOPHEN 325MGACETAMINOPHEN 500 MGACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCLACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETIC ACID

Frequently Asked Questions

Does FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE cause COUGH?

COUGH has been reported as an adverse event in 4,772 FDA reports for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE?

COUGH accounts for approximately 2.9% of all adverse event reports for FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, making it a notable side effect.

What should I do if I experience COUGH while taking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE?

If you experience cough while taking FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE Full ProfileAll Drugs Causing COUGHGlaxoSmithKline LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.